Concepedia
Statistics
Publications
3
Citations
232
H-Index
Active since
2019
Affiliations
AstraZeneca (United States)(Current)
First Pavlov State Medical University of St. Petersburg
AstraZeneca (Sweden)
University of California, Los Angeles
King's College Hospital
Konstantin Vishnevskiy is an author at AstraZeneca (United States).
Publications per year
2019–2022
A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia
Steven Fishbane, Martin L. Ford, Masafumi Fukagawa et al. · Journal of the American Society of Nephrology · 2019 · 142 citations · Full text
Emergency Potassium Normalization Treatment Including Sodium Zirconium Cyclosilicate: A Phase II, Randomized, Double‐blind, Placebo‐controlled Study (ENERGIZE)
W. Frank Peacock, Zubaid Rafique, Konstantin Vishnevskiy et al. · Academic Emergency Medicine · 2020 · 78 citations · Full text
Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE
Steven Fishbane, Martin L. Ford, Masafumi Fukagawa et al. · BMC Nephrology · 2022 · 12 citations · Full text
1–3 of 3